| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 76463480 | FILING DATE | 10/24/2002 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | CASE, LEIGH CAROLINE |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
| RUN DATE | 10/22/2008 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 10/21/2008 | ||
| LITERAL MARK ELEMENT | ALCEDO | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | ALCEDO |
| MARK DRAWING CODE | 1-TYPESET WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Alcedo Biotech GmbH |
| ADDRESS | Leobener Str. ZIG 28359 Brenmcn, |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Germany |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Chemicals used in industry and science, agriculture, horticulture and forestry, namely, proteins, peptides, nucleic acids and polynucleotides; proteins and recombinant proteins for scientific research use, antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antisense constructs for scientific research use; arrays of nucleic acids or proteins on a carrier material for scientific research use; single nucleotide polymorphism kits, also called SNP kits comprising at least one oligonucleotide or a polynucleotide for scientific research use; expression profiling kits comprised of an antibody, a protein, a peptide, a nucleic acid, a polynucleotide or a probe for scientific research use, in particular by use of PCR, immunohistochemistry or arrays; kits comprised of an antibody, a protein, a peptide, a nucleic acid, a polynucleotide or a probe for indication of specific therapy approaches for scientific research use, in particular FISH, arrays, PCR and immunohistochemistry; kits comprised of an antibody, a protein, a peptide, a nucleic acid, a polynucleotide or a probe for detection of predisposition for particular diseases for research purposes, in particular by using PCR, MALDITOF and oligo hybridization; cartilage cells for scientific research use, in particular implantable cartilage cells; fat cells for scientific research use, in particular implantable fat cells; adult and fetal stem cells for scientific research use; kits comprised of an antibody, a protein, a peptide, a nucleic acid, a polynucleotide or a probe for purification and/or separation of nucleic acids for scientific research use; kits for purification or separation of nucleic acids for scientific research use |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical and veterinary products, namely, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic antihypoxaemics; analgesics and antirheumatic drugs, pharmaceuticals functioning antihelminitics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, belneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics, antiasthmetics, cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; pharmaceutical preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro-intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinostic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; veterinary preparations for the use in the treatment of distemper, macular degeneration, cancer, infertility, arthritis, dermatitis, infections, sepsis, cardiovascular diseases, artheriosclerosis, diabetes and obesity in pets, livestock, wild animals, breeding animals and zoo animals; dietetic substances adapted for medical use, namely, food for elderly people who require medically restricted diets; medical plasters; materials for dressings, namely, wound, burn and surgical dressings; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic or agricultural use; herbicides for domestic or agricultural use; wound medicines; wound ointment; wound spray; wound tincture; wound fleece; fleece against restenosis, in particular after vascular surgery; medicaments against artheriosclerosis; medicaments against restenosis; medicaments for tissue regeneration and tissue replacement; medicaments for cartilage regeneration; pharmaceutical and veterinary preparations for diabetes treatment; pharmaceutical and veterinary preparations for diabetes prophylaxis; implantable cartilage cells; implantable fat cells; adult and fetal stem cells for medical diagnostic or therapeutic use; medicaments against obesity; pharmaceutical and veterinary preparations for pets, livestock, wild animals, breeding animals and zoo animals against tumors; gene therapeutic preparations against tumors; pharmaceutical and veterinary preparations for use in pets, livestock, wild animals, breeding animals and zoo animals against endometriosis; pharmaceutical and veterinary preparations pets, livestock, wild animals, breeding animals and zoo animals for tissue modeling for medical diagnostic or therapeutic use; recombinant proteins for medical diagnostic or therapeutic use; antibodies for medical diagnostic or therapeutic use; DNA probes for medical diagnostic use; target oligonucleotides for medical diagnostic or therapeutic use; antisense constructs; small molecules for medical diagnostic or therapeutic use; anticalines for medical diagnostic or therapeutic use; aptamers for medical diagnostic or therapeutic use; spiegelmers for medical diagnostic or therapeutic use; ribozymes for medical diagnostic or therapeutic use; RNAi for medical diagnostic or therapeutic use; specific oligonucleotides for medical diagnostic or therapeutic use; DNA probes for medical diagnostic or therapeutic use; single nucleotide polymorphism kits known as SNP kits comprised of proteins, peptides, nucleic acids or oligonucleotides for medical diagnostic use; expression profiling kits comprised of proteins, peptides, nucleic acids or oligonucleotides for medical diagnostic use, in particular by use of PCR immunohistochemistry or arrays; kits comprised of proteins, peptides, nucleic acids or oligonucleotides for medical diagnostic use for indication of specific therapy approaches, in particular FISH arrays, PCR and immunohistrochemistry; kits comprised of proteins, peptides, nucleic acids, or oligonucleotides for medical diagnostic use for detection of predisposition for particular diseases, in particular by using PCR, MALDITOF, and oligo hybridization; kits comprised of proteins, peptides, nucleic acids or oligonucleotides for medical diagnostic use for purification and/or separation of nucleic acids |
| INTERNATIONAL CLASS | 009 |
| DESCRIPTION TEXT | Scientific control apparatus and instruments, namely, microscopes, ELISA readers, scanners, fluorescence readers, phosphorirnagers; apparatus for recording, transmission or reproduction of sound or images, namely, cameras, ELISA readers, scanners, fluorescence readers, phosphorimagers; prerecorded magnetic data carriers featuring biological data of a sample or group of samples; data processing equipment, namely, ELISA readers, scanners, fluorescence readers, phosphorimagers; computers; stored computer programs for use in database management, for use as a spreadsheet, for word processing or analysis of biological data of a sample or group of samples; stored computer software for use in database management, for use as a spreadsheet, for word processing or analysis of biological data of a sample or group of samples; programs, in particular computer programs for analysis of patterns of surfaces, in particular of patterns of arrays of nucleic acids or proteins on carrier materials; automated expression profiles, namely, software for analysis of expression profiles |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Surgical, medical, dental and veterinary instruments and apparatus, namely, medical tubing, syringes, surgical implants and dental implants for the administration of fluid, gels, solids and solidifying systems; artificial limbs; orthopedic articles, namely, bone implants, cartilage implants and neck braces |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION TEXT | Treatment of materials, namely, custom construction of therapeutically useful substances into liposomes; custom construction of therapeutically useful substances in carrier substances; custom manufacture of recombinant proteins for third parties; custom manufacture of antibodies for third parties; custom manufacture of gene and tissue arrays for third parties; custom manufacture of specific oligonucleotides for third parties; custom cultivation of cells, in particular of animal and/or human cells for third parties; custom manufacture of functional nucleic acids, in particular ribozymes, aptamers, spiegelmers, RNAi and antisense oligonucleotides for third parties |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services, namely, designing laboratory protocols, manufacturing protocols and clinical trial protocols; industrial analysis and research services, namely, in the field of biology, biotechnology, biochemistry, genetics, chemistry, medicine, veterinary medicine and pharmacy; design and development of computer hardware and software; scientific research in the nature of construction of viral vectors, namely, for medication; expression profile analyses, namely, by PCR, immunohistochemistry or array hybridization; mapping of genes, in particular of chromosomes and gene libraries; hybridizations of gene libraries; single nucleotide polymorphism kit known as SNP analyses; performing FISH, arrays, PCR analysis, immunohistochemistry analysis; scientific research in the nature of detection of predisposition for developing particular diseases, in particular by using PCR or oligo hybridization; designing computer programs for others for scientific and technological services and research; designing computer programs, namely, computer programs for industrial analysis and research activities; providing a data base for scientific use on the subject of genetics, biology, pharmacy, biotechnology, medicine, veterinary medicine, biochemistry and chemistry by collecting, storing and offering of software, data, images, audio and video; providing non-downloadable software on the subject of chemical, pharmaceutical, biotechnological, biological, medical and veterinary research services, namely, legal or consulting services relating to exploitation concepts for biotechnological inventions and biotechnological know-how; scientific research in the nature of design and realization of animal experiments and design and realization of therapy studies, and analysis for specific therapy approaches |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical and veterinary services; health care for humans and animals; beauty salons; grooming salons for animals; plastic tissue regeneration; cosmetic tissue modeling and tissue regeneration |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 040 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Germany |
| APPLICATION NO. | 30221121.7/0 |
| APPLICATION FILING DATE | 04/26/2002 |
| FOREIGN REG NO. | 30221121 |
| FOREIGN REG DATE | 04/26/2002 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 04/30/2012 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/21/2008 | CNEA | O | EXAMINERS AMENDMENT MAILED | 034 |
| 10/21/2008 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 033 |
| 10/21/2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 032 |
| 10/21/2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 031 |
| 10/18/2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 030 |
| 10/18/2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 029 |
| 10/15/2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 028 |
| 04/22/2008 | CNRT | O | NON-FINAL ACTION MAILED | 027 |
| 04/22/2008 | CNRT | R | NON-FINAL ACTION WRITTEN | 026 |
| 04/09/2008 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | 025 |
| 03/24/2008 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | 024 |
| 03/06/2008 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 023 |
| 11/20/2007 | ALIE | A | ASSIGNED TO LIE | 022 |
| 10/18/2007 | I | PAPER RECEIVED | 021 | |
| 03/25/2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | 020 |
| 02/28/2005 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | 019 |
| 02/28/2005 | I | PAPER RECEIVED | 018 | |
| 02/22/2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 017 |
| 02/04/2005 | ALIE | A | ASSIGNED TO LIE | 016 |
| 01/28/2005 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 015 |
| 01/27/2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | 014 |
| 01/11/2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 013 |
| 01/11/2005 | I | PAPER RECEIVED | 012 | |
| 07/16/2004 | CNFR | O | FINAL REFUSAL MAILED | 011 |
| 08/26/2003 | 1.BD | I | Sec. 1(B) CLAIM DELETED | 010 |
| 06/18/2004 | I | PAPER RECEIVED | 009 | |
| 05/03/2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 05/03/2004 | I | PAPER RECEIVED | 007 | |
| 10/23/2003 | CNSL | S | LETTER OF SUSPENSION MAILED | 006 |
| 08/26/2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 005 |
| 09/10/2003 | CFIT | O | CASE FILE IN TICRS | 004 |
| 08/26/2003 | I | PAPER RECEIVED | 003 | |
| 02/26/2003 | CNRT | F | NON-FINAL ACTION MAILED | 002 |
| 02/21/2003 | DOCK | D | ASSIGNED TO EXAMINER | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | LISA V. MUELLER |
| CORRESPONDENCE ADDRESS | LISA V. MUELLER DYKEMA GOSSSETT PLLC 10 SOUTH WACKER DRIVE SUITE 2300 CHICAGO, IL 60606 |
| DOMESTIC REPRESENTATIVE | DYKEMA GOSSSETT PLLC |